Nerve growth factor, central nervous system apoptosis, and adrenocortical activity in aged Fischer-344/Brown Norway F1 hybrid rats

Brain Research Bulletin

Volumn 43, Issue 2, 1997, Pages 229-233

  Taglialatela, Giulio ^a   Robinson, Robert ^a   Gegg, Matthew ^a   Perez Polo, J Regino ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Adrenocortical axis; Corticosterone; Fragmented DNA; Nerve growth factor; Neuronal death

Indexed keywords

NERVE GROWTH FACTOR;

ADRENAL CORTEX; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; DNA DEGRADATION; FOREBRAIN; MALE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

AGING; ANIMALS; APOPTOSIS; BRAIN; CORTICOSTERONE; NERVE GROWTH FACTORS; RATS; RATS, INBRED F344;

EID: 0030744442     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(97)00001-4     Document Type: Article

References (40)

1. Alberch J., Perez-Navarro E., Arenas E., Marsal J. Involvement of nerve growth factor and its receptor in the regulation of the cholinergic function in aged ras. J. Neurochem. 57:1991;1483-1487.
2. Angelucci L. The hypothalamo-pituitary-adrenocortical axis: Epigenetic determinants changes with aging, involvement of NGF. Neurochem. Int. 25:1994;53-59.
3. Angelucci L., Ramacci M. T., Taglialatela G., Hulsebosch C., Morgan B., Werrbach-Perez K., Perez-Polo J. R. Nerve growth factor binding in aged rat central nervous system: Effect of acetyl-L-carnitine. J. Neurosci. Res. 20:1988;491-496.
4. Barbacid M. Neurotrophic factors and their receptors. Curr. Opin. Cell Biol. 7:1995;148-155.
5. Bothwell M. p75NTR: A receptor after all. Science. 272:1996;506-507.
6. Carson D. A., Ribeiro J. M. Apoptosis and disease. Lancet. 341:1993;1251-1254.
7. Chao M. V., Hempstead B. L. p75 and TRK - A two-receptor system. Trends Neurosci. 18:1995;321-326.
8. Crutcher K. A., Weingartner J. Hippocampal NGF levels are not reduced in the aged Fischer-344 rat. Neurobiol. Aging. 12:1991;449-454.
9. Dallman M. F., Akana S. F., Levin N., Walker C.-D., Bradbury M. J., Suemaru S., Scribner K. S. Corticosteroid and the control of function of the hypothalamo-pituitary-adrenal (HPA) axis. Ann. NY Acad. Sci. 746:1994;22-32.
10. Fischer W., Sirevaag A., Wiegand S. J., Lindsay R. M., Bjorklund A. Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA. 91:1994;8607-8611.
11. Gotz R., Koster R., Winkler C., Raulf F., Lottspeich F., Schartl M., Thoenen H. Neurotrophin-6 is a new member of the nerve growth factor family. Nature. 372:1994;266-269.
12. Hallbook F., Ibanez C. F., Persson H. Evolutionary studies of the nerve growth factor family reveal a novel member Abundantly expressed in Xenopus ovary. Neuron. 6:1991;845-858.
13. Hefti F. Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 25:1994;1418-1435.
14. Hellweg R., Fischer W., Hock C., Gage F. H., Bjorklund A., Thoenen H. Nerve growth factor level and choline acetyltransferase activity in the brain of aged rats with spatial memory impairments. Brain Res. 537:1990;123-130.
15. Henderson C. E. Role of neurotrophic factors in neuronal development. Curr. Opin. Neurobiol. 6:1996;64-70.
16. Hohn A., Leibrock J., Bailey K., Barde Y. A. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature. 344:1990;339-341.
17. Kaplan J. R., Hempstead B. L., Martin-Zanca D., Chao M. V., Parada L. F. The trk proto-oncogene product: A signal transducing receptor for NGF. Science. 252:1991;554-558.
18. Lakshmanan J. Nerve growth factor levels in mouse serum: Variations due to stress. Neurochem. Res. 12:1997;393-397.
19. Larkfors L., Ebendal T., Whittemore S. R., Persson H., Hoffer B., Olson L. Developmental appearance of nerve growth factor in the rat brain: Significant deficits in the aged forebrain. Prog. Brain Res. 78:1988;27-31.
20. Leibrock J., Lottspeich A. H., Hofer M., Hengerer B., Masiakowski P., Thoenen H., Barde Y. A. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 341:1989;149-152.
21. Lewin G. R., Barde Y. A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19:1996;289-317.
22. Lindholm D., Castren M., Hengerer B., Leingartner A., Castren E., Thoenen H. Glucocorticoids and neurotrophin gene regulation in the nervous system. Ann. NY Acad. Sci. 576:1994;195-203.
23. Loy R., Taglialatela G., Angelucci L., Heyer D., Perez-Polo J. R. Regional uptake of blood-borne nerve growth factor. J. Neurosci. Res. 39:1994;339-346.
24. Maisonpierre P. C., Belluscio L., Squinto S., Ip N. Y., Furth M. E., Lindsay R. M., Yancopulos G. D. Neurotrophin-3: A neurotrophic factor related to NGF and BDNF. Science. 247:1990;1446-1451.
25. McEwen B. S. Reexamination of the glucocorticoid hypothesis of stress and aging. Prog. Brain Res. 93:1992;365-383.
26. Mobley W. C., Schenker A., Shooter E. M. Characterization and isolation of proteolitically modified nerve growth factor. Biochemistry. 15:1981;5543-5551.
27. Olson L. NGF and the treatment of Alzheimer's disease. Exp. Neurol. 124:1994;5-15.
28. Oppenheim R. W. Cell death during development of the nervous system. Ann. Rev. Neurosci. 14:1991;453-501.
29. Otten U., Baumann J. B., Girard J. Stimulation of the pituitary-adrenocortical axis by nerve growth factor. Nature. 282:1979;413-414.
30. Perez-Polo J. R., Foreman P. J., Jackson J. R., Shan D. E., Taglialatela G., Thorpe L. W., Werrbach-Perez K. Nerve growth factor and neuronal cell death. Mol. Neurobiol. 4:1990;57-91.
31. Piovesan P., Pacifici L., Taglialatela G., Ramacci M. T., Angelucci L. Acetyl-L-carnitine treatment increases choline acetyltransferase activity and NGF levels in the CNS of adult rats following total fimbria-fornix transection. Brain Res. 633:1994;77-82.
32. Rabizadeh S., Oh J., Zhong L. T., Yang J., Bitler C. M., Butcher L. L., Bredesen D. E. Induction of apoptosis by the low-affinity NGF receptor. Science. 261:1993;345-348.
33. Sapolsky R., Krey L., McEwen B. Prolonged glucocorticoid exposures reduces hippocampal neuron number: Implications for aging. J. Neurosci. 5:1985;1121-1127.
34. Smith M. A. Hippocampal vulnerability to stress and aging: Possible role of neurotrophic factors. Behav. Brain Res. 78:1996;25-36.
35. Sprott R. L., Austad S. N. Animal models for aging research. Handbook of the biology of aging. 4th ed. 1996;3-23 Academy Press, New York.
36. Stein-Behrens B., Mattson M. P., Chang I., Yeh M., Sapolsky R. Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus. J. Neurosci. 14:1994;5373-5380.
37. Taglialatela G., Angelucci L., Scaccianoce S., Foreman P. J., Perez-Polo J. R. Nerve growth factor modulates the activation of the hypothalamo-pituitary-adrenocortical axis during the stress response. Endocrinology. 129:1991;2212-2218.
38. Taglialatela G., Navarra D., Cruciani R., Ramacci M. T., Angelucci L. Acetyl-L-carnitine increases nerve growth factor levels and choline acetyltransferase activity in the CNS of aged rats. Exp. Gerontol. 29:1994;55-66.
39. Taglialatela G., Gegg M., Perez-Polo J. R., Williams L. R., Rose G. M. Evidence for DNA fragmentation in the CNS of aged Fischer-344 rats. Neuroreport. 7:1996;977-980.
40. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.